UK markets closed

Semperit Aktiengesellschaft Holding (SEIGY)

Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
5.520.00 (0.00%)
At close: 04:59PM EDT
Full screen
Loading interactive chart…
  • EQS Group

    Semperit AG Holding delivers a strong performance in the first quarter but is behind the exceptionally high results from the corresponding period as expected

    EQS-News: Semperit AG Holding / Key word(s): Quarterly / Interim Statement/Quarter ResultsSemperit AG Holding delivers a strong performance in the first quarter but is behind the exceptionally high results from the corresponding period as expected 18.05.2022 / 07:30 The issuer is solely responsible for the content of this announcement. Semperit delivers a strong performance in the first quarter but is behind the exceptionally high results from the corresponding period as expected Revenue at Grou

  • EQS Group

    Semperit AG Holding: Annual General Meeting approves dividend of EUR 1.50 per share for 2021

    EQS-News: Semperit AG Holding / Key word(s): AGM/EGM/DividendSemperit AG Holding: Annual General Meeting approves dividend of EUR 1.50 per share for 2021 27.04.2022 / 15:28 The issuer is solely responsible for the content of this announcement.Vienna/Austria, 27 April, 2022 - At the 133rd Annual General Meeting of Semperit AG Holding, the Executive Board's proposal to pay a dividend of EUR 1.50 per share to shareholders for 2021 was approved.Herbert Ortner was re-elected as a member of the Superv

  • EQS Group

    Semperit AG Holding: Semperit posts record result again in 2021 despite difficult conditions - revenue exceed billion-euro threshold

    EQS-News: Semperit AG Holding / Key word(s): Annual Results23.03.2022 / 07:30 The issuer is solely responsible for the content of this announcement.Press releaseSemperit posts record result again in 2021 despite difficult conditions - revenue exceed billion-euro threshold- Consolidated sales increased by 27.4% to EUR 1,182.2 million in 2021- Revenue in the Industrial Sector grew by 16.2% to EUR 556.1 million and by 39.4% to EUR 626.1 million in the Medical Sector- EBITDA increased by 73.5% to EU